Covalent Bruton's tyrosine kinase inhibitor HZ-A-018 in patients with relapsed or refractory B cell malignancies: A multicenter phase I study. (linkinghub.elsevier.com)

Authors: Wu G … Shentu J Journal: iScience Published: 2026-07-17 DOI: https://doi.org/10.1016/j.isci.2026.116809